Whole Gut Microbiome Sequencing in Patients With Anorexia Nervosa
1 other identifier
observational
151
1 country
3
Brief Summary
Background. Anorexia nervosa (AN) still carries the highest fatality rate of any psychiatric disease, and less than half of the patients recover, completely refractory to any treatment. The etiology remains unknown and evidence for treatment is lacking. The intestinal microbiota and its microbiome provide humans with additional gene products which may be regarded as an organ, which contributes to multiple host metabolic pathways. Recent advances in microbial DNA sequencing technologies have resulted in metagenomic DNA analysis of whole ecosystems such as the human gut. Altered intestinal microbiota has been related to obesity and insulin resistance. Hypothetically, the intestinal microbiota could play a role in the generation and/or maintenance of the emaciation in AN. Aim. The aim of the present study is to investigate whether gut microbiota is altered in patients with AN. Subjects and methods. A cross sectional study of the gut microbiome profiles in 75 clinical, psychometric and biochemical well characterized treatment seeking females with AN. The microbiome profiles are compared with 75 age- matched healthy Danish control subjects. Perspectives. Clarifying whether the intestinal flora is implicated in the susceptibility to or maintenance of AN may provide the basis for development of new highly required treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2014
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2014
CompletedFirst Posted
Study publicly available on registry
August 15, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedFebruary 6, 2024
February 1, 2024
2 years
July 29, 2014
February 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diversity of faecal microbiota
Metagenomic analyses of microbial DNA isolated from stool samples and sequenced applying a combination of deep and untargeted shotgun sequencing.
Cross-sectional study with only one time point. The sample is delivered at a convenient time during an ongoing psychotherapeutic treatment.
Eligibility Criteria
Patients referred to specialist unit.
You may qualify if:
- Women.
- Referred to specialized eating disorder center.
- Fulfill criteria in Diagnostic and Statistical Manual of Mental Disorders - 5.
You may not qualify if:
- Age \<15 years.
- Known ongoing abuse of laxatives.
- Antibiotic treatment within the last three months.
- Inflammatory bowel disease, colorectal cancer or other bowel disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odense University Hospitallead
- University of Copenhagencollaborator
- Aarhus University Hospitalcollaborator
- Aalborg University Hospitalcollaborator
- INRA Research Center at Jouy-en-Josascollaborator
Study Sites (3)
Unit for Psychiatric Research, Aalborg University Hospital.
Aalborg, 9000, Denmark
Child and adolescent psychiatric unit. Risskov. Aarhus University Hospital.
Aarhus, 8000, Denmark
Department of Endocrinology, Center for Eating Disorders. Odense University Hospital.
Odense, 5000, Denmark
Biospecimen
Gut microbiome Serum and plasma Cells (buffy coat) Urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
René K Støving, PhD
Center for Eating Disorders, Odense University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- research secretary
Study Record Dates
First Submitted
July 29, 2014
First Posted
August 15, 2014
Study Start
September 1, 2014
Primary Completion
September 1, 2016
Study Completion
April 1, 2023
Last Updated
February 6, 2024
Record last verified: 2024-02